Beovu Action Survives Novartis’ Dismissal Motion in Va. Federal Court



DOCUMENTS
  • Order


RICHMOND, Va. — A Virginia federal judge has refused to dismiss a lawsuit targeting Novartis Pharmaceutical Corp.’s eye disease drug Beovu, ruling the claims are not impliedly preempted because they are not based solely upon misrepresentations made to the Food and Drug Administration.

In a June 30 order, Judge David J. Novak of the U.S. District Court for the Eastern District of Virginia explained that the complaint centers on the alleged misrepresentations Novartis made to the plaintiff and her doctor due to its failure to update its label.

In addition, at this stage in the case the plaintiff showed that …

FIRM NAMES
  • Hollingsworth LLP
  • Levin Papantonio Rafferty
  • Woehrle Dahlberg Yao





UPCOMING CONFERENCES




HarrisMartin's Midwest Asbestos Litigation Conference

September 21, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS



HarrisMartin's Camp Lejeune Water Contamination Litigation Conference: What Comes Next?

September 15, 2022 - Houston, TX
Four Seasons Hotel Houston

MORE DETAILS